01
无菌灌装洁净室
|
02
清洁策略
03
清洁材料
04
液体清洁剂
05
清洁方法
06
清洁效果检查
07
总结
参考文献
[1]T.E. Hansz and D.R. Linamen, “Planning, Programming, Designing, and Constructinga Cleanroom,” MDDI 17 (2), 73–86 (1995).
[2]Association for the Advancement of Medical Instrumentation, AAMI Standards and Recommended Practices: Vol. 1: Sterilization, AAMI, Arlington, VA, 1992.
[3]D.M. Carlberg, Cleanroom Microbiology for the Non-Microbiologist (Interpharm,Buffalo Grove, IL, 1995). Cleaning Aseptic Fill Areas-10 -
[4]Instituteof Environmental Sciences, Microorganisms in Cleanrooms, IESRP- CC023.1(IES, Mount Prospect, IL, 1993).
[5]D.W. Cooper, “Sterility Assurance for Cleanroom Wipers,” presentation at theannual technical meeting of the Institute of Environmental Sciences, Anaheim,CA, April 1995.
[6]D.W. Cooper, “Cleaning Surfaces with Sterile Wipers,” presentation at Medical Design and Manufacturing East, New York, June 1995.
[7]K. Hiraoka, “Particle Control in Form/Fill/Seal Systems,” in Proceedings of theInternational Conference on Particle Detection, Metrology, and Control (Instituteof Environmental Sciences and the Parenteral Drug Association, Arlington,VA, 1990), pp. 626–635.
[8]G. Van Gestel, “Clean Room Design and Operation,” in Sterilization of MedicalProducts, Vol. IV, E.R.L. Gaughran, R.L.Morrisey, and Y. Wang, Eds.(Polyscience, Montreal, 1986).
[9]J.F.Gallelli and M.J. Groves, “USP Perspectives on Particle Contamination
ofInjectable Products,” J. Pharm. Sci. Tech. 47 (6), 289–292(1993).
[10]C.L. Thompson, “Cleanroom Cleaning,” presentation at Clean-Rooms ‘94 East,Philadelphia, March 1994.
[11]M.S. Favero and W.W. Bond, “The Use of Liquid Chemical Germicides,” in SterilizationTechnology: A Practical Guide for Manufacturers and Users of HealthCare Products, R.L. Morrisey and G.B.Phillips, Eds. (Van Nostrand Reinhold,New York, 1993).
[12]G.K. Bass, “Methods of Testing Disinfectants” in Disinfection,Sterilization, and Preservation, S.S. Block, Ed. (Lea&Febiger, Philadelphia, 1977).
[13]T.H. Leahy, “Microbiology of SterilizationProcesses,” in Validation of Aseptic PharmaceuticalProcesses, F.J. Carleton and J.P. Agalloco, Eds. (Marcel Dekker, New York, 1986).
[14] J.D. Wilson, “Validation of Sanitizers,” in Validationof Aseptic Pharmaceutical Processes, F.J. Carleton and J.P. Agalloco, Eds. (Marcel Dekker, New York, 1986).
[15]Institute of Environmental Sciences, CleanroomHousekeeping—Operating and MonitoringProcedures, IES-RP-CC018.2 (IES, Mount Prospect, IL, 1992).
[16] J. Hansen et al., “Investigating AAMIRadiation Audit Results,” MDDI 16 (5), 218–222(1994).
撰稿人 | TEXWIPE
责任编辑 | 胡静
审核人 | 何发
2024-09-23
2024-09-27
2024-12-03
2024-10-04
2024-10-14
2024-10-15
2024-12-03
口服固体制剂作为临床应用非常广泛的剂型之一,其传统生产模式存在产尘量大、生产暴露环节众多以及工序复杂等特点。因此,在生产 OEB4-5 级标准的口服固体制剂时,面临的挑战是多方面的。本文从车间建设的角度出发,探讨了针对高毒性或高活性等固体制剂生产所需采取的技术手段与措施。
作者:卞强、陈宁
评论
加载更多